STOCK TITAN

Brown Capital Files Schedule 13G/A Showing 3.8M CYRX Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Brown Capital Management, LLC filed an amended Schedule 13G reporting beneficial ownership of 3,798,962 shares of CryoPort Inc. common stock, representing 7.58% of the class. The filing states Brown Capital has sole voting power over 1,529,549 shares and sole dispositive power over all 3,798,962 shares. The shares are held by various investment advisory clients of Brown Capital, which the firm says gives it beneficial ownership under Rule 13d-3 because of its discretionary authority to direct investment and voting decisions. The filing includes a certification that the holdings are held in the ordinary course of business and are not intended to influence control of the issuer.

Positive

  • Material disclosure: Brown Capital reports beneficial ownership of 3,798,962 shares (7.58%) of CryoPort, a clearly reported, material stake.
  • Transparency about nature of ownership: Filing states shares are held for advisory clients and includes a certification that holdings are in the ordinary course of business and not intended to influence control.

Negative

  • None.

Insights

TL;DR: Brown Capital holds a material 7.58% stake (3.8M shares) in CryoPort, reported on an amended Schedule 13G.

This filing discloses a clearly material passive stake by an established investment adviser. The record shows Brown Capital has sole dispositive authority over 3,798,962 shares and sole voting authority over 1,529,549 shares, and it reports the shares are held for advisory clients. The certification in Item 10 indicates the position is held in the ordinary course of business and not for control purposes. For investors, the key facts are the size of the holding and the split between voting and dispositive power; the filing itself does not assert any activist intent.

TL;DR: The schedule shows Brown Capital as a beneficial owner with discretionary authority, noting a voting versus dispositive power split.

The schedule provides governance-relevant facts: Brown Capital is reported as beneficial owner of 7.58% of CryoPort and states the shares are owned for various advisory clients, creating beneficial ownership via discretionary power. The filing quantifies 1,529,549 shares with sole voting power and 3,798,962 shares with sole dispositive power, which may matter in proxy contexts where vote mobilization or disposition timing is relevant. The Item 10 certification confirms the position is presented as non-control seeking under the rules.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Brown Capital Management, LLC
Signature:/s/ Eddie C. Brown
Name/Title:Eddie C. Brown, CEO
Date:08/13/2025

Comments accompanying signature: After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

FAQ

How many CryoPort (CYRX) shares does Brown Capital report owning?

Brown Capital reports beneficial ownership of 3,798,962 shares of CryoPort common stock.

What percentage of CYRX does Brown Capital own according to the filing?

The filing states this represents 7.58% of the outstanding class.

What voting and dispositive powers does Brown Capital report for its CYRX holdings?

The filing reports sole voting power over 1,529,549 shares, shared voting power of 0, sole dispositive power over 3,798,962 shares, and shared dispositive power of 0.

Who filed the Schedule 13G/A for CryoPort (CYRX)?

The filer is Brown Capital Management, LLC, a Maryland investment adviser with principal office at 1201 N. Calvert Street, Baltimore, Maryland 21202.

Does the filing indicate Brown Capital seeks to influence control of CryoPort?

No. Item 10 includes a certification that the securities are held in the ordinary course of business and were not acquired for the purpose of changing or influencing control of the issuer.

Is the Schedule 13G/A an amendment or an initial filing?

The document is labeled as an amended Schedule 13G ("Amendment No. 7").